Ritedose Pharmaceuticals, a division of The Ritedose Corporation, has secured Food and Drug Administration approval for formoterol fumarate inhalation solution (20 mcg/2 ml). “The approval further ...

Oral and inhaled biologics are gaining R&D investment due to patient acceptance and potential for home administration, with ...

Afrezza is a rapid-acting inhaled human insulin that is currently approved to improve glycemic control in adults with diabetes mellitus.

MannKind (Nasdaq:MNKD) announced today that the FDA accepted a supplemental biologics license for its Afrezza inhaled insulin.

MannKind (MNKD) announced that the U.S. Food and Drug Administration, FDA, has accepted the supplemental biologics license application, sBLA, ...

If approved, it would be the first needle-free insulin option for pediatric patients in 100+ years of insulin therapysBLA submission based on data from the Phase 3 INHALE-1 study PDUFA target action ...

Inhaled heparin significantly lowers the risk of death and ventilation in COVID-19 patients while also showing potential against other respiratory infections. With its unique triple-action benefits, ...